Immune Response in Hepatitis B Virus Infection

Overview

Journal Cold Spring Harb Perspect Med

Specialty General Medicine

Date 2015 Jul 3

PMID 26134480

Citations 56

Authors

Anthony Tan

Sarene Koh

Antonio Bertoletti

Affiliations

Soon will be listed here.

Abstract

Hepatitis B virus (HBV) can replicate within hepatocytes without causing direct cell damage. The host immune response is, therefore, not only essential to control the spread of virus infection, but it is also responsible for the inflammatory events causing liver pathologies. In this review, we discuss how HBV deals with host immunity and how we can harness it to achieve virus control and suppress liver damage.

Citing Articles

Developing anti-TDE vaccine for sensitizing cancer cells to treatment and metastasis control.

Meena S, Kosgei B, Soko G, Tingjun C, Chambuso R, Mwaiselage J NPJ Vaccines. 2025; 10(1):18.

PMID: 39870669 PMC: 11772600. DOI: 10.1038/s41541-024-01035-3.

Expression patterns of immune checkpoint proteins and -induced cytokines in chronic hepatitis B virus-infected and uninfected individuals: A cross-sectional study.

Segbefia S, Asandem D, Pobee A, Asare B, Prah A, Baba-Adam R Health Sci Rep. 2024; 7(8):e2280.

PMID: 39086506 PMC: 11286663. DOI: 10.1002/hsr2.2280.

Dynamical analysis of a general delayed HBV infection model with capsids and adaptive immune response in presence of exposed infected hepatocytes.

Foko S J Math Biol. 2024; 88(6):75.

PMID: 38689137 PMC: 11061075. DOI: 10.1007/s00285-024-02096-7.

Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review.

Soleiman-Meigooni S, Yarahmadi A, Kheirkhah A, Afkhami H Front Immunol. 2024; 15:1363996.

PMID: 38545106 PMC: 10965641. DOI: 10.3389/fimmu.2024.1363996.

How to address vaccine hesitancy? Lessons from National Hepatitis B Immunization Program in China.

Jiang H, Wei C Front Public Health. 2024; 12:1286801.

PMID: 38317799 PMC: 10838994. DOI: 10.3389/fpubh.2024.1286801.

References

Wieland S, Chisari F . Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005; 79(15):9369-80. PMC: 1181548. DOI: 10.1128/JVI.79.15.9369-9380.2005. View

Martinot-Peignoux M, Carvalho-Filho R, Lapalus M, Netto-Cardoso A, Lada O, Batrla R . Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients. J Hepatol. 2013; 58(6):1089-95. DOI: 10.1016/j.jhep.2013.01.028. View

Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z . Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006; 177(1):739-47. DOI: 10.4049/jimmunol.177.1.739. View

Gehring A, Haniffa M, Kennedy P, Ho Z, Boni C, Shin A . Mobilizing monocytes to cross-present circulating viral antigen in chronic infection. J Clin Invest. 2013; 123(9):3766-76. PMC: 3754243. DOI: 10.1172/JCI66043. View

Seeger C, Mason W . Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000; 64(1):51-68. PMC: 98986. DOI: 10.1128/MMBR.64.1.51-68.2000. View

Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy P, Lampertico P . Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med. 2007; 204(3):667-80. PMC: 2137916. DOI: 10.1084/jem.20061287. View

Bertoletti A, Ferrari C . Kinetics of the immune response during HBV and HCV infection. Hepatology. 2003; 38(1):4-13. DOI: 10.1053/jhep.2003.50310. View

Liu J, Zhang E, Ma Z, Wu W, Kosinska A, Zhang X . Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection. PLoS Pathog. 2014; 10(1):e1003856. PMC: 3879364. DOI: 10.1371/journal.ppat.1003856. View

van der Molen R, Sprengers D, Binda R, de Jong E, Niesters H, Kusters J . Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology. 2004; 40(3):738-46. DOI: 10.1002/hep.20366. View

10.

Durantel D, Zoulim F . Innate response to hepatitis B virus infection: observations challenging the concept of a stealth virus. Hepatology. 2009; 50(6):1692-5. DOI: 10.1002/hep.23361. View

11.

Haybaeck J, Zeller N, Wolf M, Weber A, Wagner U, Kurrer M . A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell. 2009; 16(4):295-308. PMC: 4422166. DOI: 10.1016/j.ccr.2009.08.021. View

12.

Das A, Hoare M, Davies N, Lopes A, Dunn C, Kennedy P . Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med. 2008; 205(9):2111-24. PMC: 2526205. DOI: 10.1084/jem.20072076. View

13.

Foster G, Ackrill A, Goldin R, Kerr I, Thomas H, Stark G . Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proc Natl Acad Sci U S A. 1991; 88(7):2888-92. PMC: 51345. DOI: 10.1073/pnas.88.7.2888. View

14.

Kimura K, Kakimi K, Wieland S, Guidotti L, Chisari F . Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol. 2002; 76(21):10702-7. PMC: 136645. DOI: 10.1128/jvi.76.21.10702-10707.2002. View

15.

Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A . Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut. 2009; 58(7):974-82. DOI: 10.1136/gut.2008.163600. View

16.

Sandalova E, Laccabue D, Boni C, Watanabe T, Tan A, Zong H . Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells. Gastroenterology. 2012; 143(1):78-87.e3. DOI: 10.1053/j.gastro.2012.03.041. View

17.

Zhang J, Zhang Z, Lin F, Zou Z, Xu R, Jin L . Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2009; 51(1):81-91. DOI: 10.1002/hep.23273. View

18.

Yu S, Chen J, Wu M, Chen H, Kato N, Yuan Z . Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between.... J Gen Virol. 2010; 91(Pt 8):2080-2090. DOI: 10.1099/vir.0.020552-0. View

19.

Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z . TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 2012; 8(3):e1002594. PMC: 3305436. DOI: 10.1371/journal.ppat.1002594. View

20.

Publicover J, Gaggar A, Nishimura S, Van Horn C, Goodsell A, Muench M . Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest. 2013; 123(9):3728-39. PMC: 3754256. DOI: 10.1172/JCI68182. View